Shinichi Fukuhara1, Koji Takeda1, Paul A Kurlansky1, Yoshifumi Naka1, Hiroo Takayama2. 1. Division of Cardiac, Thoracic, and Vascular Surgery, Columbia University Medical Center, New York, NY. 2. Division of Cardiac, Thoracic, and Vascular Surgery, Columbia University Medical Center, New York, NY. Electronic address: ht2225@cumc.columbia.edu.
Abstract
OBJECTIVES: Venoarterial extracorporeal membrane oxygenation (ECMO) use as a bridge to transplant is extremely infrequent in adults. We investigated patient outcomes of the use of ECMO as bridge to transplant. METHODS: United Network of Organ Sharing provided de-identified patient-level data. Between 2003 and 2016, 25,168 adult recipients were identified. Of these, 107 (0.4%) were bridged with ECMO and 6148 (24.4%) were bridged with a continuous-flow left ventricular assist device. RESULTS: Patients in ECMO group were younger, more likely to have severely disabled functional status, shorter waitlist time, and were more frequently mechanically ventilated than were patients in the continuous-flow left ventricular assist device group. Kaplan-Meier analysis demonstrated estimated posttransplant survival of 73.1% versus 93.1% at 90 days (P < .001) and 67.4% versus 82.4% at 3 years (P < .001) in ECMO and continuous-flow left ventricular assist device groups, respectively. Analysis of a propensity-matched cohort still demonstrated a lower survival in ECMO group at 90 days (74.8% vs 88.8%; P = .025) and 3 years (69.3% vs 82.2%; P = .054). Among the ECMO patients, multivariable logistic and Cox regression analyses showed model for end-stage liver disease excluding international normalized ratio (MELD-XI) score to be the sole contributor to both 90-day (odds ratio, 1.94; 95% confidence interval, 1.00-3.76; P = .050) and 3-year mortality (hazard ratio, 1.47; 95% confidence interval, 1.16-1.88; P = .002). ECMO-supported patients with a high MELD-XI score (>17) were associated with poor posttransplant survival compared with those with a low MELD-XI score (<13) (90 day, 54.4% vs 85.0% [P < .001] and 3 year, 49.5% vs 73.5% [P < .001]). CONCLUSIONS: Bridge to transplant with ECMO was associated with increased early/mid-term mortality, especially in patients with a high MELD-XI score who demonstrated > 50% 3-year mortality. These findings may help to inform future organ allocation policies.
OBJECTIVES: Venoarterial extracorporeal membrane oxygenation (ECMO) use as a bridge to transplant is extremely infrequent in adults. We investigated patient outcomes of the use of ECMO as bridge to transplant. METHODS: United Network of Organ Sharing provided de-identified patient-level data. Between 2003 and 2016, 25,168 adult recipients were identified. Of these, 107 (0.4%) were bridged with ECMO and 6148 (24.4%) were bridged with a continuous-flow left ventricular assist device. RESULTS:Patients in ECMO group were younger, more likely to have severely disabled functional status, shorter waitlist time, and were more frequently mechanically ventilated than were patients in the continuous-flow left ventricular assist device group. Kaplan-Meier analysis demonstrated estimated posttransplant survival of 73.1% versus 93.1% at 90 days (P < .001) and 67.4% versus 82.4% at 3 years (P < .001) in ECMO and continuous-flow left ventricular assist device groups, respectively. Analysis of a propensity-matched cohort still demonstrated a lower survival in ECMO group at 90 days (74.8% vs 88.8%; P = .025) and 3 years (69.3% vs 82.2%; P = .054). Among the ECMO patients, multivariable logistic and Cox regression analyses showed model for end-stage liver disease excluding international normalized ratio (MELD-XI) score to be the sole contributor to both 90-day (odds ratio, 1.94; 95% confidence interval, 1.00-3.76; P = .050) and 3-year mortality (hazard ratio, 1.47; 95% confidence interval, 1.16-1.88; P = .002). ECMO-supported patients with a high MELD-XI score (>17) were associated with poor posttransplant survival compared with those with a low MELD-XI score (<13) (90 day, 54.4% vs 85.0% [P < .001] and 3 year, 49.5% vs 73.5% [P < .001]). CONCLUSIONS: Bridge to transplant with ECMO was associated with increased early/mid-term mortality, especially in patients with a high MELD-XI score who demonstrated > 50% 3-year mortality. These findings may help to inform future organ allocation policies.
Authors: Oliver K Jawitz; Marat Fudim; Vignesh Raman; Benjamin S Bryner; Adam D DeVore; Robert J Mentz; Carmelo Milano; Chetan B Patel; Jacob N Schroder; Joseph G Rogers Journal: JACC Heart Fail Date: 2020-05-14 Impact factor: 12.035
Authors: Michiel Morshuis; Frank Bruenger; Tobias Becker; Annette Kempa-Haupt; Lukasz Kizner; Riad Al-Khalil; Jan F Gummert; René Schramm Journal: Ann Cardiothorac Surg Date: 2019-01
Authors: Darae Kim; Jin Oh Choi; Jaewon Oh; Hyun Jai Cho; Sung Ho Jung; Hae Young Lee; Seok Min Kang; Jae Joong Kim; Eun Seok Jeon Journal: Korean Circ J Date: 2019-03-20 Impact factor: 3.243
Authors: Diyar Saeed; Evgenij Potapov; Antonio Loforte; Michiel Morshuis; David Schibilsky; Daniel Zimpfer; Julia Riebandt; Federico Pappalardo; Matteo Attisani; Mauro Rinaldi; Davide Pacini; Assad Haneya; Faiz Ramjankhan; Dirk W Donker; Ulrich P Jorde; Wolfgang Otto; Julia Stein; Dmytro Tsyganenko; Ameen Al-Naamani; Radi Wieloch; Rafael Ayala; Jochen Cremer; Michael Borger; Artur Lichtenberg; Jan Gummert Journal: Ann Cardiothorac Surg Date: 2021-05